Home > Healthcare > Medical Services > Diagnostic Services > Cholesterol Testing Services Market
Cholesterol Testing Services Market Size
- Report ID: GMI9548
- Published Date: May 2024
- Report Format: PDF
Cholesterol Testing Services Market Size
Cholesterol Testing Services Market was valued at around USD 20.5 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032. Cholesterol testing services refer to diagnostic procedures and laboratory testing offered by healthcare providers or clinical laboratories to measure levels of cholesterol in a patient's blood. Cholesterol testing is an essential component of cardiovascular risk assessment and disease prevention. The procedure typically involves collecting a blood sample from the patient, which is then analyzed to determine the levels of various types of cholesterol, including low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides.
Moreover, increasing use of cardiac arrhythmia monitoring devices, rising adoption of cardiology information system (market size is estimated to account for USD 2.4 billion by the end of year 2032), growing awareness about prediabetes, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the stimulating factors fostering the growth of the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Cholesterol Testing Services Market Size in 2023: | USD 20.5 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 8.1% |
| 2024 – 2032 Value Projection: | USD 41.3 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 185 |
| Tables, Charts & Figures: | 280 |
| Segments covered: | Test Type, Product Type, Application, Age Group, Service Provider, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Cholesterol Testing Services Market Scope
